Summary Forty-nine ovarian tumours were examined for loss of heterozygosity (LOH) on chromosome 5 using eight microsatellite markers spanning both arms, including one at the APC locus. LOH on Sq was a frequent event, detectable in 23 of 49 (47%) tumours, whereas 5p LOH was detected in only 1 of 22 tumours (5%). Six tumours showed partial LOH on 5q, enabling the candidate region to be localised to a 22 cM region proximal to APC, flanked by D5S424 and D5S644. An association was found between 5q LOH and TP53 mutation, with 18 of 23 (78%) tumours with LOH on Sq also harbouring a TP53 mutation. LOH on Sq was observed in 6 of 18 (33%) stage I tumours, suggesting that it may be an early event in the molecular pathogenesis of certain ovarian carcinomas.
segments is often associated with the loss of function of TSGs and is frequently observed in a variety of human malignancies (reviewed by Weinberg, 1992) . In ovarian cancer, multiple chromosomal deletions on chromosomes 3, 6, 11, 17, 18 and 22 among others have been reported (Okamoto et al., 1991; Sato et al., 1991; Yang-Feng et al., 1993; Cliby et al., 1993; Foulkes et al., 1993a,b; Tavassoli et al., 1993; Englefield et al., 1994) .
However, apart from TP53 and BRCAI, the TSGs which are the target of these allelic losses have not been cloned and in many cases even their approximate locations have yet to be defined. In some cases, LOH analysis has identified regions containing TSGs with proven involvement in other tumour types prompting investigations of the role of the TSG in ovarian cancer Foulkes et al., 1994) . In particular, allelic deletions on chromosome 5 have been observed in ovarian carcinoma with the common region consistent with inactivation of the APC gene. (Cliby et al., 1993; Allan et al., 1994) . However, in an extensive mutation analysis, Allan et al. (1994) found no evidence ofAPC mutation, arguing against its involvement in ovarian tumorigenesis. They were able to confirm that chromosome 5 LOH was common in ovarian cancer but were unable to refine the location of the putative TSG beyond an exclusion of distal 5p. In an attempt to refine the location of the candidate region we have analysed for LOH using seven polymorphic microsatellite markers on chromosome Sq (Shepherd, 1989) . DNA was isolated from tumours and blood as described by Foulkes et al. (1993a) .
Polymerase chain reaction Microsatellite markers for chromosome 5 were amplified by the polymerase chain reaction (PCR) using the primers listed in Table I SSCP and sequencing analysis of TP53 PCR amplification of exons 5-8 of TP53 were performed using the primers and conditions described by Milner et al. (1993) . SSCP analysis of the samples was performed as described by Campbell et al. (1994) . Tumour samples showing abnormal band shifts were repeated together with matching normal DNA to ensure that it was not due to a germline polymorphism. DNA sequencing was performed on some of the tumours with band shifts using a dideoxy termination protocol (Foulkes et al., 1995) .
Statistical analyses
Statistical analysis was performed using Spearman's rank correlation (Gardner and Altman, 1989 Figure 1 . The smallest common region of deletion defined by these tumours is flanked by the markers D5S424 and D5S644 representing a genetic distance of approximately 22 cM (Gyapay et al., 1994) . This region at 5ql3.1-21 is proximal to the APC locus.
Analysis of TP53 mutation SSCP analysis of TP53 exons 5-8 detected abnormal band shifts in 22 of the 49 (45%) tumours examined (Table II and  Table IV) in agreement with the frequency observed in a number of other studies (Foulkes et al., 1995; Kohler et al., 1993a,b) . No band shifts were detected in the matching normal DNA from these samples, indicating that these were somatic alterations and not germline polymorphisms. Twelve of these tumours were sequenced, and in all cases a somatic mutation was detected. There was a striking concordance of TP53 mutation with chromosome 5q deletions (P<0.001; al., 1992a,b; Hosoe et al., 1994) . In ovarian cancers, chromosome 5q LOH has been reported by some groups to be an infrequent event (Ehlen and Dubeau, 1990; Sato et al., 1991; Yang-Feng et al., 1993) due to differences in the number, location and type of interstitial deletions permitting the refinement of the polymorphic markers used in each study as well as the small candidate TSG locus to the 22cM region. flanked by size of the tumour collections. The most comprehensive of D5S424 and D5S644 at 5q 13.1-21. This region is proximal these studies used five markers on each chromosomal arm and detected LOH in 50% of the 27 tumours examined . The LOH was consistent with the loss of APC, but no mutations were detected by SSCP in any of the exons containing published mutations suggesting that another Only when the Sq TSG is cloned and it can be examined for specific inactivating mutations will it be possible to determine the true relationship between the two events.
